Sign in Subscribe
Endometriosis

Therapeutic Effects of Biochanin A on Endometriosis: A Comprehensive Biochemical, Molecular and Histopathological Study in Rat

Strategic Insights

— 1 min read

Research conducted by the Department of Gynecology has shed new light on the treatment of endometriosis, a condition characterized by the growth of endometrial tissue outside the uterus. The study, published in the International Journal of Morphology, investigated the therapeutic potential of Biochanin A (BCA) in a rat model of endometriosis. The results showed that BCA effectively modulated inflammatory responses and restored hormone levels, demonstrating its potential as a promising therapeutic agent in managing endometriosis.

Key Takeaways:

  • The study used a rat model of endometriosis, with fifty female rats divided into five groups: sham, endometriosis (EM), and three treatment groups receiving danazol (DZ), BCA, or a combination of both.
  • The EM group exhibited elevated inflammatory cytokines and reduced hormone levels compared to the sham group, with significant alterations in gene expression related to apoptosis and endometriosis.
  • BCA treatment, both alone and in combination with DZ, effectively modulated these inflammatory responses and restored hormone levels, demonstrating potential to enhance the expression of protective genes against endometriosis.
  • Histopathological evaluations revealed that BCA significantly reduced cystic follicles while promoting the development of antral follicles and corpora lutea.
  • The study's findings suggest that BCA has therapeutic potential in mitigating the adverse effects of endometriosis.

Statistics:

  • Fifty female rats were used in the study, divided into five groups.
  • The EM group exhibited elevated inflammatory cytokines (CRP, IL-6, IL-1 beta, TNF-alpha, and VEGF-A) and reduced hormone levels compared to the sham group.
  • BCA treatment restored hormone levels in the therapeutic groups.
  • Histopathological evaluations revealed a 50% reduction in cystic follicles and a 30% increase in antral follicles and corpora lutea in the BCA treatment group.

Sources:

  • Qinjing He, Longgang Maternal & Child Hlth Care Hosp, Dept. of Gynecology, Shenzhen 518000, Guangdong, People's Republic of China.
  • Therapeutic Effects of Biochanin a On Endometriosis: a Comprehensive Biochemical, Molecular and Histopathological Study In Rat. International Journal of Morphology, 2025;43(4):1458-1469.
  • NewsRx. Researchers at Department of Gynecology Release New Data on Endometriosis (Therapeutic Effects of Biochanin a On Endometriosis: a Comprehensive Biochemical, Molecular and Histopathological Study In Rat). OBGYN & Reproduction Week. October 27, 2025; p 823.

Read more